Germany
psychoactive | Business of Cannabis | April 1
Cannabis legalisation shows no signs of the harm critics predicted
Psychedelic therapy
psychoactive | Latin American Post | April 1
Mexico’s cartels hamper the consideration of novel treatments
Extension
psychoactive | Business of Cannabis | April 2
Cannabis program “ZüriCan” to continue for 2 more years
Interventional psychiatry
psychoactive | Ecstatic Integration | April 3
Big pharma shows big interest
Neural fingerprint
psychoactive | The Guardian | April 6
Psilocybin leads to cross-talk between brain systems
More
psychoactive | NYT | April 7
How psychedelics affect the brain
End of life distress
psychoactive | CBC News | April 7
Terminally ill Canadian patient had to help himself to psilocybin
Other thoughts
psychoactive | DoubleBlind | April 10
Psychedelics and telepathy
France
psychoactive | The Lancet | April 11
IV racemic ketamine approved for the treatment of adult severe suicidal crisis
Aborting a bad trip
psychoactive | The Microdose | April 13
Five questions for emergency physician Gregory Yates
England
psychoactive | Psychedelic Alpha | April 13
Psychedelic research at Cambridge University
Pills & ills
science | BPS Journal | April 14
Capturing addiction recovery
Ibogaine in the US
psychoactive | Psychedelics Today | April 16
Practitioner statement of responsible development
Hidden biodiversity
science | High Country News | April 17
Mycorhizal fungi networks need more protection
Fallout
eco2 | The Conversation | April 17
Faraway wars have worrying ecological consequences – also in Switzerland
Psychedelic-Assisted Therapy
psychoactive | Ecstatic Integration | April 17
Two deaths and two serious incidents in Switzerland within two years.
By decree
psychoactive | NYT | April 19
Restrictions on psychedelic drugs loosened in the US
Neurobiology
science | Aeon | April 20
Facts about the brain you want to know
Reefer Madness
psychoactive | NYT | April 20
The propaganda that keeps on giving
German Survey
psychoactive | Leafie | April 20
Use of prescription drugs down by 83% since medicinal cannabis legalisation
Sports
psychoactive | Reasons to be cheerful | April 23
Can psychedelics help athletes recover from brain injury?
A full brain?
science / The Conversation / April 24
What we remember makes all the difference
Chemical frontiers
psychoactive | Focal Points | April 25
Hidden risks of psychedelic treatment
PTSD
psychoactive | The Guardian | April 30
Active-duty US solders to be treated with MDMA next year